Testing effectiveness (Phase 2)Study completedNCT02624167
What this trial is testing
Determine the Safety, Tolerability and Efficacy NW-3509A in Patients With Chronic Schizophrenia
Who this might be right for
Chronic Schizophrenia
Newron Pharmaceuticals SPA 90